Advisors Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
38,029
-9,234
| -20% | -$143K | 0.01% | 911 |
|
|
2025
Q1 | $703K | Buy |
47,263
+7,852
| +20% | +$117K | 0.01% | 856 |
|
|
2024
Q4 | $522K | Sell |
39,411
-11,815
| -23% | -$156K | 0.01% | 913 |
|
|
2024
Q3 | $728K | Buy |
51,226
+14,992
| +41% | +$213K | 0.01% | 814 |
|
|
2024
Q2 | $469K | Sell |
36,234
-13,547
| -27% | -$175K | 0.01% | 915 |
|
|
2024
Q1 | $691K | Buy |
49,781
+3,315
| +7% | +$46K | 0.01% | 826 |
|
|
2023
Q4 | $663K | Sell |
46,466
-17,410
| -27% | -$248K | 0.01% | 819 |
|
|
2023
Q3 | $988K | Buy |
63,876
+6,628
| +12% | +$103K | 0.02% | 723 |
|
|
2023
Q2 | $899K | Sell |
57,248
-19,710
| -26% | -$310K | 0.02% | 777 |
|
|
2023
Q1 | $1.27M | Buy |
76,958
+7,485
| +11% | +$123K | 0.03% | 678 |
|
|
2022
Q4 | $1.08M | Sell |
69,473
-7,887
| -10% | -$123K | 0.02% | 721 |
|
|
2022
Q3 | $1M | Buy |
77,360
+8,940
| +13% | +$116K | 0.02% | 722 |
|
|
2022
Q2 | $961K | Sell |
68,420
-10,843
| -14% | -$152K | 0.02% | 764 |
|
|
2022
Q1 | $1.14M | Buy |
79,263
+19,700
| +33% | +$282K | 0.02% | 767 |
|
|
2021
Q4 | $812K | Sell |
59,563
-3,321
| -5% | -$45.3K | 0.01% | 873 |
|
|
2021
Q3 | $1.03M | Buy |
62,884
+9,277
| +17% | +$152K | 0.02% | 809 |
|
|
2021
Q2 | $902K | Buy |
53,607
+9,811
| +22% | +$165K | 0.01% | 864 |
|
|
2021
Q1 | $800K | Buy |
43,796
+19,268
| +79% | +$352K | 0.01% | 885 |
|
|
2020
Q4 | $446K | Buy |
24,528
+7,650
| +45% | +$139K | 0.01% | 1003 |
|
|
2020
Q3 | $301K | Buy |
16,878
+12,024
| +248% | +$214K | 0.01% | 1064 |
|
|
2020
Q2 | $87K | Buy |
+4,854
| New | +$87K | ﹤0.01% | 1328 |
|